DennisS.CharneyMD

Dean of the Icahn School of Medicine at Mount Sinai and President for Academic Affairs for the Mount Sinai Health System

Join to view full profile

Dr. Charney is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Charney's full profile

Already have an account?

Office
1 Gustave L Levy Pl
Annenberg 21-86, Box 1217
New York, NY 10029
Phone+1 212-241-8884

Education & Training

Yale-New Haven Medical CenterResidency, Psychiatry, 1978 - 1981
Yale-New Haven Medical CenterInternship, Transitional Year, 1977 - 1978
Pennsylvania State University College of MedicineClass of 1977

Certifications & Licensure

NY State Medical License 2005 - 2025
MD State Medical License 2000 - 2006
DC State Medical License 2001 - 2002
CT State Medical License 1979 - 2001
American Board of Psychiatry and Neurology Psychiatry

Awards, Honors, & Recognition

Elected Member Institute of Medicine, 2000
Whos Who in Medicine and Healthcare Marquis Whos Who

Clinical Trials

Effectiveness of an NK1 Antagonist in PTSD Start of enrollment: 2005 Sep 01
Randomized, Placebo-controlled Trial of an AMPAkine in Major Depressive Disorder Start of enrollment: 2005 Mar 01
Withdrawn
Phase 2
Substance P Antagonist in the Treatment of Posttraumatic Stress Disorder Start of enrollment: 2006 Sep 01
Completed
Phase 2
Intranasal Administration of Neuropeptide Y in Healthy Male Volunteers Start of enrollment: 2010 Jan 01
Completed
Phase 2
Ketamine as a Rapid Treatment for Post-traumatic Stress Disorder (PTSD) Start of enrollment: 2009 Jan 01
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

442 citations
Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression.
Rebecca B. Price, Matthew K. Nock, Dennis S. Charney, Sanjay J. Mathew
Biological Psychiatry. 2009-09-01
242 citations
Positron emission tomographic imaging of neural correlates of a fear acquisition and extinction paradigm in women with childhood sexual-abuse-related post-traumatic st...
J. Douglas Bremner, Eric Vermetten, Christian Schmahl, Viola Vaccarino, Meena Vythilingam
Psychological Medicine. 2005-06-01
35 citations
Association of Depression and Cardiovascular Disease.
Chayakrit Krittanawong, Neil Sagar Maitra, Yusuf Kamran Qadeer, Zhen Wang, Sonya Fogg
The American Journal of Medicine. 2023-09-01

Authored Content

A Resilience Prescription for Covid-19 and Other Traumatic EventsJune 2021

Press Mentions

Adolescent Medicine Trailblazer Angela Diaz, MD, PhD, MPH, Steps Down as Director of Adolescent Health Center and Chief of the Division of Adolescent Medicine at Mount Sinai Health SystemSeptember 30th, 2024
Cardiologist Valentin Fuster Named President of Mount Sinai HeartOctober 18th, 2022
In Memoriam: Steven M. Southwick, MD, 1948-2022April 29th, 2022
Join now to see all

Grant Support

Improving Annenberg 23 In Support Of Translational ResearchNational Center For Research Resources2010
Continuous Intravenous Ketamine In Major Depressive DisorderNational Center For Research Resources2008–2009
Evaluation Of The Efficacy Of The NK1 Antagonist Gr205171 In PTSDNational Center For Research Resources2006–2009
General Clinical Research CenterNational Center For Research Resources2005–2009
Randomized,Placebo-Controlled Trial Of An Ampakine In Major Depressive DisorderNational Center For Research Resources2007–2008
The Alpha 2C Adrenoreceptor In Post-Traumatic Stress DisorderNational Center For Research Resources2007
Clinical Assessment Of Novel Anti-Depressant-AnxiolyticsNational Institute Of Mental Health2003–2007
Randomized, Placebo-Controlled Trial/Ampakine DepressionNational Institute Of Mental Health2006
Tryptophan Depletion In Remitted Depressed PatientsNational Institute Of Mental Health2003
Soy Isoflavones For The Treatment Of Major DepressionNational Institute Of Mental Health2003
Hydrocortisone Induced Changes In Glucose MetabolismNational Institute Of Mental Health2003
Glucocorticoid And Mineralocorticoid Receptor FunctionNational Institute Of Mental Health2003
Felbamate For Treatment-Resistant Bipolar DepressionNational Institute Of Mental Health2003
Efficacy Of Memantine For Major DepressionNational Institute Of Mental Health2003
Efficacy Of Clozapine For Treatment-Resistant ManiaNational Institute Of Mental Health2003
Antiglucocorticoid Therapy In Bipolar DepressionNational Institute Of Mental Health2003
A2-Adrenoreceptor (AR) Subtype PolymorphismsNational Institute Of Mental Health2003